GlassScriptPhysician profile
Stephen P Kyser
NPI 1003113671
$4,015.46
in general payments reported to CMS, 2019-2025
14 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $324 · 2023: $628 · 2024: $2,641 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,029 · Travel and Lodging: $1,518 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.69 |
| Travel and Lodging | $1,518.26 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,792.53 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $342.21 | 2023-2024 | Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $271.62 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $104.40 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $100.83 | 2022-2025 | |
| Astellas Pharma US INC | $98.99 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $80.39 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $53.39 | 2022-2025 | Eliquis |
| Abbott Laboratories | $53.29 | 2022-2023 | Cardiomems |
| Amgen INC. | $36.66 | 2023-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $26.55 | 2022-2023 | Brilinta |
| Novo Nordisk INC | $20.94 | 2023 | Ozempic, Rybelsus |
| Pfizer INC. | $18.31 | 2025 | |
| Alnylam Pharmaceuticals INC. | $15.35 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kyser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.